Comparative in vitro activity of vancomycin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus and Enterococcus faecium in the Tohoku district of Japan

Chemotherapy

Volumn 44, Issue 5, 1998, Pages 318-323

  Lutfor, Afzalunnessa Binte ^a   Kikuchi, Toru ^a   Tokue, Yutaka ^a   Takahashi, Hiroshi ^a   Shoji, Satoru ^a   Fujimura, Shigeru ^a   Nukiwa, Toshihiro ^a   Watanabe, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Enterococcus faecium; Methycillin resitant Staphylococcus aureus; Quinupristin dalfopristin; Teicoplanin; Vancomycin

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; EUROPE; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

EID: 0031838077     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007129     Document Type: Article

References (18)

1. Emori TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-442.
2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-146.
3. Boyce JM, Opal SM, Chow AW, Zervos MJ, Bynoe GP, Sherman CB, Romulo R, Fortna S, Medeiros A: Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32: 1148-1153.
4. Tenover FC, Tokars J, Swenso J, Paul S, Spitalny K, Jarvis W: Ability of clinical laboratory to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993;31: 1695-1699.
5. Murray BE: The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65.
6. Tomasz A: 'Special report' on multiple antibiotic resistant pathogenic bacteria. N Engl J Med 1994;330: 1247-1251.
7. Facklam RR, Collins MD: Identification of Enterococcus species isolated from human infection by a conventional test scheme. J Clin Microbiol 1989;27:731-734.
8. Hewitt JH, Coe AW, Parker MT: The detection of methicillin resistance in Staphylococcus aureus. J Med Microbiol 1969;2:443-456.
9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National Committee for Clinical Laboratory Standards. Villanova, NCCLS, 1990.
10. Uttley AH, Naidoo J: Vancomycin resistant enterococci. Lancet 1988;i: 57-58.
11. Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann G, Hakenbeck R, Antanassova V, Witte W: Enterococcus faecium strains with vanA mediatec high level glycopeptide resistance isolated from animal foodstuff and fecal samples of human in the community. Microb Drug Resist 1995;1:265-272.
12. Witte W, Klare I: Glycopeptide resistant Enterococcus faecium outside hospital: A commentary. Microb Drug Resist 1995;1:259-263.
13. Soussy CJ, Acar JF, Cluzel R, Courvalin P, Duval J, Fleurette J, Megraud F, Meyran M, Thabaut A: A collaborative study of the in-vitro sensitivity to quinupristin/dalfopristin of bacteria isolated in seven hospitals in France. J Antimicrob Chemother 1992;30(suppl A):53-58.
14. Collins LA, Malanoski GJ, Eliopoulos GM, Wennersten CB, Ferraro MJ, Moellering RC: In vitro activity of quinupristin/dalfopristin, an injectable Streptogramin antibiotic, against vancomycin resistant and Gram positive organisms. Antimicrob Agents Chemother 1993;37: 598-601.
15. Goto S, Miyazaki S, Kaneko Y: The in-vitro activity of quinupristin/dalfopristin against Gram positive cocci. J Antimicrob Chemother 1992; 30(suppl A):25-28.
16. Schouten MA, Hoogkamp-Korstanje JAA: Comparative in vitro activities of quinupristin/dalfopristin against Gram-positive bloodstream isolates. J Antimicrob Chemother 1997;40:213-219.
17. Lee SM, Chong Y: Characteristics of methicillin resistant Staphylococcus aureus isolated from wounds from Korean patients. J Infect Chemother 1996;2:130-135.
18. Entenza JM, Drugeon H, Glauser MP, Moreillon P: Treatment of experiment endocarditis due to erythromycin susceptible or resistant methicillin resistant Staphylococcus aureus with quinupristin/dalfopristin. Antimicrob Agents Chemother 1995;39:1419-1424.